Madrigal Pharmaceuticals Inc (MDGL)
216.11
+5.52
(+2.62%)
USD |
NASDAQ |
May 02, 16:00
215.99
-0.12
(-0.06%)
After-Hours: 20:00
Madrigal Pharmaceuticals Total Return Level: 216.11 for May 2, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 02, 2024 | 216.11 |
May 01, 2024 | 210.59 |
April 30, 2024 | 204.02 |
April 29, 2024 | 201.07 |
April 26, 2024 | 193.33 |
April 25, 2024 | 194.38 |
April 24, 2024 | 204.65 |
April 23, 2024 | 218.38 |
April 22, 2024 | 213.49 |
April 19, 2024 | 212.04 |
April 18, 2024 | 222.26 |
April 17, 2024 | 228.34 |
April 16, 2024 | 232.98 |
April 15, 2024 | 231.37 |
April 12, 2024 | 236.59 |
April 11, 2024 | 245.27 |
April 10, 2024 | 244.67 |
April 09, 2024 | 249.34 |
April 08, 2024 | 248.64 |
April 05, 2024 | 243.04 |
April 04, 2024 | 241.46 |
April 03, 2024 | 245.23 |
April 02, 2024 | 244.50 |
April 01, 2024 | 255.74 |
March 28, 2024 | 267.04 |
Date | Value |
---|---|
March 27, 2024 | 258.81 |
March 26, 2024 | 247.62 |
March 25, 2024 | 247.62 |
March 22, 2024 | 248.20 |
March 21, 2024 | 255.27 |
March 20, 2024 | 258.99 |
March 19, 2024 | 265.68 |
March 18, 2024 | 283.23 |
March 15, 2024 | 270.37 |
March 14, 2024 | 243.57 |
March 13, 2024 | 272.98 |
March 12, 2024 | 262.67 |
March 11, 2024 | 260.15 |
March 08, 2024 | 255.32 |
March 07, 2024 | 251.03 |
March 06, 2024 | 257.38 |
March 05, 2024 | 248.49 |
March 04, 2024 | 246.56 |
March 01, 2024 | 251.63 |
February 29, 2024 | 236.20 |
February 28, 2024 | 254.23 |
February 27, 2024 | 239.80 |
February 26, 2024 | 232.57 |
February 23, 2024 | 236.54 |
February 22, 2024 | 248.53 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
55.89
Minimum
Jan 27 2022
312.00
Maximum
Apr 28 2023
130.65
Average
104.37
Median
Jun 11 2020
Total Return Level Benchmarks
Eli Lilly and Co | 2175.84 |
Viking Therapeutics Inc | 75.76 |
Akero Therapeutics Inc | 19.69 |
89bio Inc | 8.86 |
Geron Corp | 3.95 |